Home » Topics » BioWorld Science

BioWorld Science
RSS

In vivo studies of HRX-0215 in acute and chronic liver disease

Nov. 22, 2021

ALP and LECT2 are markers of SZN-043 target engagement and Wnt pathway activation

Nov. 22, 2021

Neurons increase cholesterol synthesis during chronic myelin disease

Nov. 22, 2021

FAUST, a novel interpretable machine-learning method for unbiased discovery in single-cell cytometry

Nov. 19, 2021

Zika virus antagonism of mitophagy drives pathological proinflammatory chemokine expression

Nov. 19, 2021

Study offers insights into post-MI fibrosis

Nov. 19, 2021

Replication stress response defects signature predicts ICB response in nonhypermutated cancers

Nov. 19, 2021

p21-controlled immunoclearance mechanism identified in senescent cells

Nov. 19, 2021

Researchers develop new model of heart failure with preserved ejection fraction

Nov. 19, 2021

Artizan and Biohaven begin therapeutic discovery and development program in Parkinson's

Nov. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...